Back to Westfield Capital Management Co. LP Westfield Capital Management Co. LP

GILD

11 quarters

Position history for Westfield Capital Management Co. LPWestfield Capital Management Co. LP's holdings in Gilead Sciences, Inc.

Yes. Westfield Capital Management holds 1,287,629 shares of GILD (Gilead Sciences), worth $162.7M, as of its Q2 2026 13F filing. It increased the position from 26,690 shares in Q1 2026. Westfield Capital Management has held GILD since Q4 2025, across 3 quarterly 13F filings. GILD is 0.5% of Westfield Capital Management's reported 13F portfolio.

Current Value

$162.7M

Current Shares

1.3M

Total Value Change

+$157.7M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+4724.4%
$162.7M0.5%$125.63
69
2026-Q1
Decreased
26,690
-35.7%
$3.7M0.0%$137.68
0
2025-Q4
New
41,515
-
$5.1M0.0%$120.57
37
2024-Q1
Exited
0
-100.0%
$00.0%$67.94
0
2023-Q4
Increased
100,981
+2.1%
$8.2M0.0%$74.37
28
2023-Q3
Increased
98,888
+6.6%
$7.4M0.1%$68.18
29
2023-Q2
Increased
92,751
+6.9%
$7.1M0.0%$69.44
29
2023-Q1
Increased
86,760
+3.8%
$7.2M0.1%$74.04
28
2022-Q4
Increased
83,595
+5.9%
$7.2M0.1%$75.89
29
2022-Q3
Decreased
78,929
-2.9%
$4.9M0.0%$54.08
0
2022-Q2
New
81,255
-
$5M0.0%$53.58
37

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used